Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,291,721
-
Share change
-
+85,894
-
Total reported value
-
$81,080,858
-
Price per share
-
$62.77
-
Number of holders
-
101
-
Value change
-
+$5,249,953
-
Number of buys
-
30
-
Number of sells
-
36
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2023
As of 31 Mar 2023,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,291,721 shares.
The largest 10 holders included
MORGAN STANLEY, Gerber Kawasaki Wealth & Investment Management, UBS Group AG, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, LPL Financial LLC, Royal Bank of Canada, JPMORGAN CHASE & CO, YHB Investment Advisors, Inc., and CreativeOne Wealth, LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.